Literature DB >> 15241675

Anemia in pediatric dialysis patients in end-stage renal disease network 5.

Jeffrey J Fadrowski1, Susan L Furth, Barbara A Fivush.   

Abstract

To identify demographic and clinical characteristics associated with failure to achieve hemoglobin levels >/=11 g/dl in prevalent pediatric end-stage renal disease (ESRD) patients, a cross-sectional analysis of patient clinical data collected by the Mid-Atlantic Renal Coalition in conjunction with the 2000 and 2001 ESRD Clinical Performance Measures Projects was performed. Ninety-nine patients (mean age 12.6 years, SD 5.4) contributed 119 observations to this analysis. Of patients on hemodialysis, 36.6% were anemic, and 39.5% of patients on peritoneal dialysis (PD) were anemic. Associations between age, race, gender, assigned cause of ESRD, Kt/V, transferrin saturation, time on dialysis, serum albumin, dialysis modality, and the achievement of target hemoglobin were examined. In multivariate logistic regression analyses examining age, dialysis modality, time on dialysis, and serum albumin, each 1-year increase in age was significantly associated with hemoglobin levels <11 g/dl [adjusted odds ratio (OR) 1.18, 95% confidence interval (CI) 1.06-1.32] and PD patients were more than twice as likely to have hemoglobin levels <11 g/dl (adjusted OR 2.62, 95% CI 0.98-7.04). Patients on dialysis for 6 months or more were less likely to be anemic than those on dialysis for less than 6 months (adjusted OR 0.39, 95% CI 0.16-0.99). In conclusion, increasing age, dialysis for less than 6 months, and treatment with PD were predictive of anemia in this population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15241675     DOI: 10.1007/s00467-004-1544-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  18 in total

1.  II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: update 2000.

Authors: 
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

2.  Compliance in adolescents with epilepsy or diabetes.

Authors:  E Chigier
Journal:  J Adolesc Health       Date:  1992-07       Impact factor: 5.012

3.  Adolescent hemodialysis: results of the 2000 ESRD Clinical Performance Measures Project.

Authors:  Diane L Frankenfield; Alicia M Neu; Bradley A Warady; Sandra L Watkins; Aaron L Friedman; Barbara A Fivush
Journal:  Pediatr Nephrol       Date:  2002-01       Impact factor: 3.714

4.  Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors.

Authors:  M M Mitsnefes; S R Daniels; S M Schwartz; R A Meyer; P Khoury; C F Strife
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

5.  Duration of dialysis and its relationship to dialysis adequacy, anemia management, and serum albumin level.

Authors:  M V Rocco; M R Bedinger; R Milam; J W Greer; W M McClellan; D L Frankenfield
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

6.  Exercise tolerance after anaemia correction with recombinant human erythropoietin in end-stage renal disease.

Authors:  E Baraldi; G Montini; S Zanconato; G Zacchello; F Zacchello
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

Review 7.  Should hemoglobin be normalized in patients with chronic kidney disease?

Authors:  Lesley Stevens; Caroline Stigant; Adeera Levin
Journal:  Semin Dial       Date:  2002 Jan-Feb       Impact factor: 3.455

8.  Treatment compliance in childhood and adolescence.

Authors:  C K Tebbi
Journal:  Cancer       Date:  1993-05-15       Impact factor: 6.860

9.  Serum albumin concentration-related Health Care Financing Administration quality assurance criterion is method-dependent: revision is necessary.

Authors:  C R Blagg; R J Liedtke; J D Batjer; B Racoosin; T K Sawyer; M J Wick; L Lawson; K Wilkens
Journal:  Am J Kidney Dis       Date:  1993-02       Impact factor: 8.860

Review 10.  The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee.

Authors:  Cornelis H Schröder
Journal:  Pediatr Nephrol       Date:  2003-05-15       Impact factor: 3.714

View more
  9 in total

1.  Report of an NIH task force on research priorities in chronic kidney disease in children.

Authors:  Russell W Chesney; Eileen Brewer; Marva Moxey-Mims; Sandra Watkins; Susan L Furth; William E Harmon; Richard N Fine; Ronald J Portman; Bradley A Warady; Isidro B Salusky; Craig B Langman; Debbie Gipson; Peter Scheidt; Harold Feldman; Frederick J Kaskel; Norman J Siegel
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

2.  Mental health and psychosocial adjustment in pediatric chronic kidney disease derived from the KNOW-Ped CKD study.

Authors:  Na Ri Kang; Yo Han Ahn; Eujin Park; Hyun Jin Choi; Seong Heon Kim; Heeyeon Cho; Min Hyun Cho; Jae Il Shin; Joo Hoon Lee; Young Seo Park; Hae Il Cheong; Hee Gyung Kang; Il-Soo Ha; Young Sook Kwack; Kyoung Hee Han
Journal:  Pediatr Nephrol       Date:  2019-06-20       Impact factor: 3.714

3.  Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease.

Authors:  Bradley A Warady; Mazen Y Arar; Gary Lerner; Arline M Nakanishi; Catherine Stehman-Breen
Journal:  Pediatr Nephrol       Date:  2006-05-25       Impact factor: 3.714

4.  How to define anemia in children with chronic kidney disease?

Authors:  Guido Filler; Kyle Mylrea; Janusz Feber; Hubert Wong
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

5.  Disparate outcomes in pediatric peritoneal dialysis patients by gender/race in the End-Stage Renal Disease Clinical Performance Measures project.

Authors:  Meredith A Atkinson; Alicia M Neu; Barbara A Fivush; Diane L Frankenfield
Journal:  Pediatr Nephrol       Date:  2008-05-16       Impact factor: 3.714

6.  Hemoglobin level and risk of hospitalization and mortality in children on peritoneal dialysis.

Authors:  Erin K Dahlinghaus; Alicia M Neu; Meredith A Atkinson; Jeffrey J Fadrowski
Journal:  Pediatr Nephrol       Date:  2014-08-10       Impact factor: 3.714

7.  Using dynamic treatment regimes to understand erythropoietin-stimulating agent hyporesponsiveness.

Authors:  Ari H Pollack; Assaf P Oron; Joseph T Flynn; Raj Munshi
Journal:  Pediatr Nephrol       Date:  2018-04-04       Impact factor: 3.714

8.  Impact of Pediatric Chronic Dialysis on Long-Term Patient Outcome: Single Center Study.

Authors:  Daniella Levy Erez; Irit Krause; Amit Dagan; Roxana Cleper; Yafa Falush; Miriam Davidovits
Journal:  Int J Nephrol       Date:  2016-08-15

Review 9.  Effect of peritoneal dialysis versus hemodialysis on renal anemia in renal in end-stage disease patients: a meta-analysis.

Authors:  Wan-Ning Wang; Wen-Long Zhang; Tao Sun; Fu-Zhe Ma; Sensen Su; Zhong-Gao Xu
Journal:  Ren Fail       Date:  2016-11-17       Impact factor: 2.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.